Status:
COMPLETED
Exploring Mechanisms and Morphology of QT Interval Prolongation
Lead Sponsor:
Herlev and Gentofte Hospital
Conditions:
Long Qt Syndrome 1-2
Sudden Cardiac Death
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The projects will try and optimise the risk stratification for patients with Long QT syndrome by investigating how the exposure of physical and acoustic stress will affect the QT-dynamics and if beta ...
Detailed Description
The aim of the projects is to try and optimise the risk stratification for patients with Long QT syndrome by investigating how the exposure of physical and acoustic stress will affect the QT-dynamics ...
Eligibility Criteria
Inclusion
- Verified Long QT syndrome mutation, subtype 1 or 2.
- over 18 years of age
Exclusion
- Atrioventricular block,
- Left bundle branch block,
- Left ventricular hypertrophy,
- Pace rhythm,
- ST-deviations \>1 mm),
- Left ventricular ejection fraction \<50 % and significant valvulopathy,
- Unstable psychiatric disease
- Unstable cardiovascular disease.
Key Trial Info
Start Date :
June 27 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2019
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT03291145
Start Date
June 27 2017
End Date
January 1 2019
Last Update
February 21 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Herlev-Gentofte Hospital
Herlev, Copenhagen, Denmark, 2730